Showing results (51-60 of 162) with videos related to
Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|March 27, 2026
Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaDaichi Takizawa, Hirotaka Arai, Mitsuhiko Shibasaki, et al.Internal Medicine (Tokyo, Japan)|March 17, 2023
Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using PembrolizumabSanae Uehara, Atsushi Naganuma, Nozomi Furuichi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 29, 2026
Efficacy and Safety of Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma in the Caudate Lobe: A Comparative Study With Radiofrequency AblationYuki Tamura, Hirotaka Arai, Hiroki Kiyohara, et al.BMC Cancer|October 17, 2019
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trialMasaaki Kondo, Manabu Morimoto, Satoshi Kobayashi, et al.Journal of Gastroenterology and Hepatology|April 11, 2024
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agentsHideko Ohama, Atsushi Hiraoka, Toshifumi Tada, et al.Oncology|December 6, 2020
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World StudyTakeshi Hatanaka, Atsushi Naganuma, Mitsuhiko Shibasaki, et al.Journal of Liver Cancer|November 6, 2023
Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective studyKazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.Journal of Gastroenterology and Hepatology|May 27, 2025
Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class BTakeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.Oncology|July 11, 2022
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World StudyHidetoshi Yasuoka, Atsushi Naganuma, Eishin Kurihara, et al.Internal Medicine (Tokyo, Japan)|December 13, 2021
Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/PibrentasvirTakeshi Hatanaka, Satoru Kakizaki, Takuya Kaburagi, et al.Pageof 17